Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

A status update for a Phase 2 trial evaluating CT1812 in early Alzheimer's disease. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• CT1812

Snippet

Sponsor: Cognition Therapeutics | Conditions: Early Alzheimer's Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING